Fast Facts: Chronic Obstructive Pulmonary Disease is an invaluable resource for all healthcare professionals, full of practical information on the early recognition, stabilization and successful management of this multifaceted disease.
In this fully updated third edition of 'Fast Facts: Chronic Obstructive Pulmonary Disease', the authors take a comprehensive look at: • the disease process, its causes and progression • the relationship between asthma and COPD • the ...
The aim of this book is to provide physicians with the information they need to make that accurate diagnosis and offer early, appropriate treatment.
Stephen T. Holgate, Jo A. Douglass. Fast Facts: Asthma First published 1999; second edition 2006; reprinted 2007; third edition 2010 Fourth edition March 2013 Text © 2013 Stephen T Holgate, Jo A Douglass © 2013 in this edition Health ...
Similarly, loss of cells that release gamma-aminobutyric acid has been demonstrated in the caudate nucleus of patients with Huntington's disease. In Alzheimer's disease, there is a loss of cholinergic neurons projecting from the basal ...
Lipton RB, Silberstein SD, Saper JR et al. Why headache treatment fails. Neurology 2003;60:1064–70. Loder E, Rizzoli P. Tension-type headache. BMJ 2008;336:88–92. Maizels M, Burchette R. Rapid and sensitive paradigm for screening ...
Those who achieved more than 10% loss of bodyweight achieved the best outcome. (a) Kaplan–Meier curve for AF-free survival without the use of rhythm control strategies. (b) Kaplan–Meier curve for total AFfree survival (after ...
'Fast Facts: Travel Medicine' is an invaluable practice resource which provides expert practical coverage of all aspects of health problems that may be incurred during travel abroad.
Alex Slack, Diane K. Newman, Alan J. Wein. Fast Facts: Bladder Disorders First published 2008 Second edition August 2011 Text © 2011 Alex Slack, Diane K Newman, Alan J Wein © 2011 in this edition Health Press Limited Health Press ...
'Fast Facts: Headaches' equips the primary care physician with the knowledge required to accurately investigate, assess and treat (or refer) the patient presenting with disabling primary headache. • Enables physicians to distinguish ...
'Fast Facts: Pyruvate Kinase Deficiency' will be of interest to primary care providers, hematologists, oncologists, pediatricians, internal medicine specialists, hematology nurses and medical students; indeed, anyone who wishes to learn ...
Bell WR, Braine HG, Ness PM et al. Improved survival in thrombotic thrombocytopenic purpurahemolytic uremic syndrome. Clinical experience in 108 patients. 2. Peyvandi F, Scully M, Kremer N Engl J Med 1991;325:398–403 ...
Now in its fifth edition, this ever-popular handbook is a neatly packaged, up-to-date resource for the busy clinician and team, to help investigate, diagnose and successfully treat children and adults with a wide range of seizure disorders.
Contrasting 'clinical research' with routine 'clinical care', this short colorful book describes types of digital measurement and how to use and validate digital measures in different settings.
Benign prostate hyperplasia: a review of the year's progress from bench to clinic. Curr Opin Urol 2011;21:22–6. Kirby RS, Gilling PJ. Fast Facts: Benign Prostatic Hyperplasia, 7th edn. Oxford: Health Press, 2011. Kirby RS, Patel MI.
It provides a concise overview of treatment options, in both the front-line and relapsed/refractory settings, with particular focus on the novel targeted agents that have overcome many adverse prognostic factors, improving overall survival.
In den letzten Jahren kam es zu einem noch nie dagewesenen Anstieg unseres Wissens über das Management des Ovarialkarzinoms; von Diagnose und Genetik bis hin zur Operation und neuen zielgerichteten Behandlungsmethoden.
'Fast Facts: Early Breast Cancer' provides a comprehensive overview of stage 0, I, II and IIIA disease, including the latest thinking on the risk of developing breast cancer and the value (or not) of screening, alongside the importance of ...
Since the last edition of this book, 'no evidence of disease activity' (NEDA) has been proposed as a new treatment target, early data on the first pharmacological treatments for progressive MS have emerged, and the first remyelination trial ...
Updates in this new edition include: • distinguishing between patients with primary (low renin) and secondary aldosteronism • greater use of home BP measurement in clinical decision-making • the latest thinking on BP treatment ...